EXTELLIA THERAPEUTICS

WIPO WIPO 2016

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark EXTELLIA THERAPEUTICS was filed as Word mark on 06/29/2016 at the World Intellectual Property Organization.

Trademark Details Last update: April 7, 2020

Trademark form Word mark
File reference 1309554
Countries Australia China em India Japan Mexico Russia Turkey
Base trademark US No. 86864972, January 4, 2016
Application date June 29, 2016
Expiration date August 26, 2019

Trademark owner

Suite 303,
25 First Street
US

Trademark representatives

254 Commercial Street Portland ME 04101 US

goods and services

05 Pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells based on gene, genome and cellular editing, modulation, modification, engineering, regulation, and repair therapy for use in human therapeutics; diagnostic preparations for medical purposes based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy
42 Scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; scientific study and research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; design of bioinformatic algorithms and models for use in scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services

Trademark history

Date Document number Area Entry
March 10, 2020 2020/15 Gaz US RAW: Total Ceasing Effect
February 7, 2019 2019/6 Gaz TR Rejection
November 15, 2017 2017/46 Gaz MX Rejection
October 26, 2017 2017/43 Gaz CN Rejection
September 25, 2017 2017/39 Gaz IN Rejection
May 11, 2017 2017/20 Gaz RU Rejection
February 24, 2017 2017/9 Gaz EM Rejection
January 10, 2017 2017/2 Gaz AU Rejection
December 28, 2016 2017/1 Gaz JP Rejection
June 29, 2016 2016/37 Gaz US Registration

ID: 141309554